Global Influenza Diagnostics Market 2017-2021


◆タイトル:Global Influenza Diagnostics Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥371,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥477,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About Influenza DiagnosticsThe global influenza diagnostics market is expected to grow at a moderate pace in the forecast period. The factors that are expected to drive the market in the forecast period includes endemic and pandemic outburst of influenza disease, new strains and lineages in the viruses due to genetic modification will continuously challenge the market for new products, and increasing public awareness.

Technavio’s analysts forecast the global influenza diagnostics market to grow at a CAGR of 8.56% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global influenza diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of influenza diagnostics.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Influenza Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Alere
• Becton Dickinson
• bioMerieux
• Quidel

[Other prominent vendors]
• Autoimmune Technologies
• Biocartis
• EKF Diagnostics
• Grifols
• Meridian Bioscience
• Response Biomedical
• SA Scientific
• Sekisui Medical

[Market driver]
• Increasing demand for POC diagnostics
• For a full, detailed list, view our report

[Market challenge]
• Ethical issues related to pandemic influenza
• For a full, detailed list, view our report

[Market trend]
• Potential opportunities for POL
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by indication
• Influenza A
• Influenza B
• Influenza C

PART 07: Market segmentation by product
• Immunodiagnostics
• Market size and forecast
• Market size and forecast
• Molecular diagnostics
• Market size and forecast

PART 08: Market segmentation by end-users
• Hospitals and diagnostic laboratories
• Academic and research institutes
• Home care

PART 09: Geographical segmentation
• Influenza diagnostics market in Americas
• Influenza diagnostics market in EMEA
• Influenza diagnostics market in APAC

PART 10: Market drivers
• Increasing demand for POC diagnostics
• Growing demand for automation and system integration
• Climatic condition-dependent influenza diagnostic testing

PART 11: Impact of drivers

PART 12: Market challenges
• Challenges related to laboratory diagnosis for emerging influenza viruses
• Ethical issues related to pandemic influenza
• Strained laboratory budgets and lowering reimbursement affecting instrument sales

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Potential opportunities for POL
• Leasing of influenza diagnostics instruments
• Technological advancements in detection of influenza diseases

PART 15: Vendor landscape

PART 16: Key vendor analysis
• Alere
• Becton Dickinson
• bioMerieux
• Quidel
• Key companies to watch
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global influenza diagnostics market overview
Exhibit 03: Global influenza diagnostics market ($ billions)
Exhibit 04: Market analysis of influenza diagnostics market 2016
Exhibit 05: cobas Liat Influenza A/B: Features and specifications
Exhibit 06: Five forces analysis
Exhibit 07: Types of human influenza viruses
Exhibit 08: Influenza A products
Exhibit 09: Influenza A and B products
Exhibit 10: Global influenza immunodiagnostics market 2016-2021 ($ millions)
Exhibit 11: Immunodiagnostics metrics analysis
Exhibit 12: Global influenza POCT market 2016-2021 ($ billions)
Exhibit 13: Pros and cons of POCT testing
Exhibit 14: POCT metrics analysis
Exhibit 15: Global influenza molecular diagnostics market 2016-2021 ($ millions)
Exhibit 16: Molecular diagnostics metrics analysis
Exhibit 17: Global influenza diagnostics market segmentation by end-users 2015
Exhibit 18: Various types of reference measurement services
Exhibit 19: Global clinical reference laboratory services market share by service provider 2015 and 2020 (% share)
Exhibit 20: Global influenza diagnostics market by geography 2016-2021
Exhibit 21: Influenza diagnostics market in Americas overview
Exhibit 22: Influenza diagnostics market in Americas ($ billions)
Exhibit 23: Influenza diagnostics market in EMEA overview
Exhibit 24: Influenza diagnostics market in EMEA ($ millions)
Exhibit 25: Influenza diagnostics market in APAC overview
Exhibit 26: Influenza diagnostics market in APAC ($ millions)
Exhibit 27: Advantages of POC diagnostics
Exhibit 28: CLIA-waived influenza diagnostics products
Exhibit 29: Typical seasonal patterns of influenza activity in selected countries
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Leasing of influenza diagnostics instruments
Exhibit 33: Competitive structure analysis of global influenza diagnostics market 2016
Exhibit 34: Global influenza diagnostics market: Competitive landscape
Exhibit 35: Alere: Strength assessment
Exhibit 36: Alere: Strategy assessment
Exhibit 37: Alere: Opportunity assessment
Exhibit 38: Becton Dickinson: Strength assessment
Exhibit 39: Becton Dickinson: Strategy assessment
Exhibit 40: Becton Dickinson: Opportunity assessment
Exhibit 41: bioMerieux: Strength assessment
Exhibit 42: bioMerieux: Strategy assessment
Exhibit 43: bioMerieux: Opportunity assessment
Exhibit 44: Quidel: Strength assessment
Exhibit 45: Quidel: Strategy assessment
Exhibit 46: Quidel: Opportunity assessment


Alere, Becton Dickinson, bioMerieux, Quidel, Autoimmune Technologies, Biocartis, EKF Diagnostics, Grifols, Meridian Bioscience, Response Biomedical, SA Scientific, and Sekisui Medical.





★調査レポート[インフルエンザ診断の世界市場2017-2021:POCT、分子診断] (Global Influenza Diagnostics Market 2017-2021 / IRTNTR12232)販売に関する免責事項
[インフルエンザ診断の世界市場2017-2021:POCT、分子診断] (Global Influenza Diagnostics Market 2017-2021 / IRTNTR12232)についてEメールでお問い合わせ